Research at the Institute of Biomedicine is divided into three functional units: 1) Infection and Immunity, 2) Integrative Physiology and Pharmacology and 3) Cancer research. Research at our Institute includes both biomedical basic research and translational research, and the unit division expresses our research priorities.
We encourage creative interdisciplinary combination of research topics via collaboration of the individual research groups and the three units. In addition, we collaborate locally with clinical researchers, with other institutes of our university and with the Åbo Akademi University. We are also widely networked with numerous national and international universities and public and private research institutes.
Research services
Recent publications
Expressing OsiSAP8, a Zinc-Finger Associated Protein Gene, Mitigates Stress Dynamics in Existing Elite Rice Varieties of the 'Green Revolution' (2022)
Sustainability
(Refereed journal article or data article (A1))
Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood (2022)
Frontiers in Immunology
(Refereed journal article or data article (A1))
Epidemiological Study of p16 Incidence in Head and Neck Squamous Cell Carcinoma 2005-2015 in a Representative Northern European Population (2022)
Cancers
(Refereed journal article or data article (A1))
Increased HLA class II risk is associated with a more aggressive presentation of clinical type 1 diabetes (2022)
Acta Paediatrica
(Refereed journal article or data article (A1))
Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma (2022)
Oral Oncology
(Refereed journal article or data article (A1))
Recent doctoral dissertations
Expressing OsiSAP8, a Zinc-Finger Associated Protein Gene, Mitigates Stress Dynamics in Existing Elite Rice Varieties of the 'Green Revolution' (2022)
Sustainability
(Refereed journal article or data article (A1))
Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood (2022)
Frontiers in Immunology
(Refereed journal article or data article (A1))
Epidemiological Study of p16 Incidence in Head and Neck Squamous Cell Carcinoma 2005-2015 in a Representative Northern European Population (2022)
Cancers
(Refereed journal article or data article (A1))
Increased HLA class II risk is associated with a more aggressive presentation of clinical type 1 diabetes (2022)
Acta Paediatrica
(Refereed journal article or data article (A1))
Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma (2022)
Oral Oncology
(Refereed journal article or data article (A1))